0 followers
NeuExcell is an early stage gene therapy company focusing on neurodegenerative diseases. They have developed a disruptive neural repair technology that utilizes in vivo astrocyte-to-neuron conversion.
CEOs
Cellphire Therapeutics
3 followers
Entos
1 follower
Thermo Fisher Scientific
166 followers
Regeneron
94 followers
Agilent Technologies
63 followers
Alexion Pharmaceuticals
34 followers
Charles River Laboratories
11 followers
Cytiva
10 followers
Calico
6 followers
Merck
216 followers
AbbVie
178 followers
Explore companies